Latest Lead News

WT Financial Group and its joint venture Investco have incorporated two new 'Hubcos' to consolidate advisory firms and pursue strategic acquisitions, marking a significant expansion in their financial advice platform.

SRJ Technologies clarifies its financial position and strategic rationale behind a recent capital raise and acquisition of a UAE entity, addressing ASX concerns over its viability and voluntary suspension.

Locksley Resources has completed an oversubscribed capital raising and appointed Tribeca Capital to drive its U.S.-focused critical minerals strategy, targeting rare earths and antimony supply chains aligned with government initiatives.

Green Technology Metals (GT1) and EcoPro Innovation have successfully produced battery-grade lithium hydroxide monohydrate from spodumene concentrate sourced from GT1’s Seymour project in Ontario, confirming high lithium recovery and low impurities.

Australian Gold and Copper Ltd reports strong flotation and leaching test results from its Achilles deposit, marking a key step toward a maiden Mineral Resource Estimate.

xReality Group has secured a $2.1 million grant from the Australian Government to fast-track AI enhancements in its Operator XR tactical training platform, aiming to solidify its leadership in law enforcement and defense training worldwide.

AMP Limited reported a 9.2% rise in underlying net profit after tax for the first half of 2025, alongside a declared interim dividend, while navigating fresh legal challenges.

Prophecy International and Complexica announce a strategic merger to form MergeCo, an ASX-listed AI pure play with enhanced scale, product synergies, and growth potential.

Prophecy International Holdings has agreed to acquire Complexica in a transformative merger, creating Complexica Group Limited, an ASX-listed AI pure play software company with enhanced scale and growth potential.

Argent Minerals is fast-tracking its Kempfield Polymetallic Project in NSW, launching diamond drilling and metallurgical testwork to explore early production options and support a scoping study.

Nyrada’s Phase I clinical trial for Xolatryp™ concludes with positive safety and pharmacokinetic results, paving the way for a Phase IIa study in acute myocardial infarction patients.

ABx Group has sent a 100 kg bulk sample from its Deep Leads rare earths project to ANSTO for production of a high-purity mixed rare earth carbonate, confirming exceptional grades and extraction potential. The milestone underscores ABx’s progress toward low-cost, environmentally friendly rare earth supply.